The Digital Thread:
How Genomics Can Link Processes from Bench to Bedside
Genomics may be the key to identifying, curing and preventing diseases, changing the life sciences industry as we know it.
Join us and industry experts at 11:00 a.m. ET on March 25 as we analyze and align on a future vision for genomics.
This discussion will explore:
- The promises and challenges genomics presents.
- The unique innovation advantages and challenges larger NYSE companies face compared to smaller biotechs.
- How to democratize access to essential data across the R&D value chain.
- The critical importance of implementing and complying with appropriate consent policies and procedures.
- When this will all become a reality.
THURSDAY, MARCH 25
11:00 a.m. - 12:00 p.m. ET
SPEAKERS
Dr. Chris Waller, VP, Chief Scientist, EPAM Systems
Hal Stern, VP & CIO, R&D, The Janssen Pharmaceutical Companies of Johnson & Johnson
John Apathy , Vice President, IT for Research and Early Development, Bristol-Myers Squibb
Dr. Marc Grodman, CEO, Genosity
Connect with NYSE
By submitting this form you hereby expressly grant permission to use the information included thereunder to contact you for the purposes of sending periodic updates about ICE and/or its affiliates.
Your contact information will not be used for any purpose other than that for which your consent has been given. To learn more about our privacy policy, please click here.
© 2021 Intercontinental Exchange, Inc. All rights reserved. Intercontinental Exchange and ICE are trademarks of Intercontinental Exchange, Inc. or its affiliates. For more information regarding registered trademarks see: intercontinentalexchange.com/terms-of-use
